Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · July 05, 2023

Reduction in Risk for Major Adverse Cardiac Events After Screening for CVD Risk Factors in Patients With Hidradenitis Suppurativa

Clinical and Experimental Dermatology


Additional Info

Clinical and Experimental Dermatology
Opportunity for significant reduction in risk of major adverse cardiac events with screening for cardiovascular disease risk factors in hidradenitis suppurativa
Clin Exp Dermatol 2023 Jun 13;[EPub Ahead of Print], N Kearney, R Hughes, C McCourt, D O'Kane, B Kirby

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading